Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry

Avinash Dinmohamed, Yvette van Norden, O (Otto) Visser, EFM Posthuma, PC Huijgens, Pieter Sonneveld, AA van de Loosdrecht, Mojca Jongen - Lavrencic

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2449-2451
Number of pages3
Issue number12
Publication statusPublished - 2015

Research programs

  • EMC MM-02-41-03

Cite this